General Biologicals (4117)

Currency in TWD
16.20
+0.20(+1.25%)
Closed·
4117 Scorecard
Full Analysis
Operates with a significant debt burden
4117 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.8016.50
52 wk Range
12.0524.90
Key Statistics
Bid/Ask
9.03 / 9.49
Prev. Close
16.2
Open
16.2
Day's Range
15.8-16.5
52 wk Range
12.05-24.9
Volume
91.64K
Average Volume (3m)
144.71K
1-Year Change
-18.16%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4117 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
May have trouble making interest payments on debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

General Biologicals Company Profile

General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally. It offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point of care testing services. The company also provides COVID-19, digital pathology, and contract development manufacturing organization solutions; blood screening services for hepatitis and HIV; and biomaterial, such as antibody biomaterials and human plasma. In addition, it offers a range of oral care products under the oh care brand. Further, the company serves its diagnostic solutions through clinics and laboratories. General Biologicals Corporation was founded in 1973 and is headquartered in Hsinchu City, Taiwan.

Compare 4117 to Peers and Sector

Metrics to compare
4117
Peers
Sector
Relationship
P/E Ratio
−4.4x−24.4x−0.5x
PEG Ratio
0.400.020.00
Price/Book
3.4x2.7x2.6x
Price / LTM Sales
3.9x30.1x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock−17.4%6.9%Unlock

Earnings

Latest Release
May 27, 2025
EPS / Forecast
-1.92 / --
Revenue / Forecast
140.65M / --
EPS Revisions
Last 90 days

4117 Income Statement

FAQ

What Stock Exchange Does General Biologicals Trade On?

General Biologicals is listed and trades on the Taipei Exchange stock exchange.

What Is the Stock Symbol for General Biologicals?

The stock symbol for General Biologicals is "4117."

What Is the General Biologicals Market Cap?

As of today, General Biologicals market cap is 973.19M.

What Is General Biologicals's Earnings Per Share (TTM)?

The General Biologicals EPS (TTM) is -3.69.

From a Technical Analysis Perspective, Is 4117 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has General Biologicals Stock Split?

General Biologicals has split 4 times.

How Many Employees Does General Biologicals Have?

General Biologicals has 81 employees.

What is the current trading status of General Biologicals (4117)?

As of 07 Aug 2025, General Biologicals (4117) is trading at a price of 16.20, with a previous close of 16.20. The stock has fluctuated within a day range of 15.80 to 16.50, while its 52-week range spans from 12.05 to 24.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.